SCHEMBL2480089

SCHEMBL2480089

NS(=O)(=O)c1ccc(C(=O)NCc2ccc(F)c(F)c2F)cc1.NS(=O)(=O)c1ccc(N2CCCC2=O)c([N+](=O)[O-])c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.60
GAA P10253 1/20 0.60
CA2 P00918 3/20 0.59
ALDH1A1 P00352 4/20 0.51
HTT P42858 2/20 0.51
SMN1; SMN2 Q16637 3/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
HPGD P15428 1/20 0.45
EPHX2 P34913 1/20 0.44
NR1H4 Q96RI1 1/20 0.44
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
MAPT P10636 3/20 0.41
LMNA P02545 2/20 0.41
MAPK1 P28482 1/20 0.41
GFER P55789 1/20 0.41
P2RX7 Q99572 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL677962 0.78 KDM4E (1.00) KDM4EGAACA2ALDH1A1HTT
SCHEMBL678985 0.77 CA2 (1.00) KDM4ECA2EPHX2NR1H4
SCHEMBL7230840 0.68 MEN1 (0.65) KDM4EGAAALDH1A1HTTSMN1; SMN2
SCHEMBL29805501 0.67 KDM4E (0.60) KDM4EGAAALDH1A1HTTSMN1; SMN2
SCHEMBL25433246 0.66 KDM4E (0.73) KDM4EGAACA2ALDH1A1HTT
SCHEMBL678099 0.65 CA2 (0.70) KDM4ECA2EPHX2NR1H4
SCHEMBL677539 0.65 CA2 (0.70) KDM4ECA2EPHX2NR1H4
SCHEMBL29758010 0.64 SMN1; SMN2 (0.67) KDM4EGAAALDH1A1HTTSMN1; SMN2
SCHEMBL23466602 0.64 SMN1; SMN2 (0.67) KDM4EGAAALDH1A1HTTSMN1; SMN2
SCHEMBL1972790 0.63 MAPT (0.71) ALDH1A1SMN1; SMN2L3MBTL1HPGDCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2377530-A2 Modulation of neurogenesis by PDE inhibition Braincells, Inc. (US) 2011-10-19 EP disclosed